Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
A Narrow Definition of Clinical Robustness: Comment on “Assessing the Clinical Robustness of Digital Health Startups: Cross-sectional Observational Analysis”
Jaclyn Marshall;
Alexandra N. Yurkovic;
Todd Thames;
Ami Parekh
ABSTRACT
This letter to the editor is in response to the article “Assessing the Clinical Robustness of Digital Health Startups: Cross-sectional Observational Analysis” by Day et al. We appreciate the authors highlighting the importance of assessing the quality and impact of the growing digital health industry. However, we found the definition of clinical robustness to be too narrow and not applicable to the broad digital health industry. In this letter, we argue that clinical robustness should also consider accreditations, externally validated methodologies, and peer-reviewed studies demonstrating impact.